Optimata Ltd.
Optimata Ltd. is named on 1 US grants and 5 published applications in this corpus. Its most frequent classification is G16H (Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the).
- Granted patents
- 1
- Published applications
- 5
- Inventors
- 11
- Granted in 2026 so far
- 0
- Most recent grant
- 12 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
By publication year.
Technology areas
Share of 6 documents
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the6
- A61PTherapeutic uses of medicines3
- G16CComputational chemistry2
- G01NInvestigating or analysing materials by determining their chemical or physical properties1
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or1
Recent patents
- System and Methods for Optimized Drug Delivery and Progression of Diseased and Normal Cells13 Sep 2007US 2007/0213961 A1
- System and method of evaluation of stochastic interactions of a soluble ligand with a target cell population for optimization of drug design and delivery8 Mar 2007US 2007/0054331 A1
- System and methods for optimized drug delivery and progression of diseased and normal cells27 Jul 2006US 2006/0167637 A1
- Interactive technique for optimizing drug development from the pre-clinical phases through phase-IV3 Jun 2004US 2004/0107084 A1
- System and methods for optimized drug delivery and progression of diseased and normal cells22 May 2003US 2003/0097220 A1
Most cited
By later US patents